Full Length Research Paper
References
|
Aqil M, Ahad A, Sultana Y, Najmi AK, Saha NA (2007). validated HPLC method for estimation of metoprolol in human plasma. Acta Chromatographica 19:130-140. |
|
|
Center for Drug Evaluation and Research (CDER) (1997). Extended release solid oral dosage forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations; USA. US Department of Health &Human services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). |
|
|
Food and Drug Administration (FDA) (2017). Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system, CDER (2000). Food and Drug Administration, US Department of Health and Human services, Center for Drug Evaluation and Research (CDER). |
|
|
Gibaldi M, Perrier D, Marcel D (1982). Pharmacokinetics New York, (2nd edn, revised and expanded). Mandal U, Ray KK, Gowda V, Ghosh A, Pal TK (2007). In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Journal of Pharmacognosy and Pharmacology 59(7):971-976. |
|
|
Grbic S, Parojcic J, Ibric S, Djuric Z (2011). In vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation. Aaps Pharmscitech 12(1):165-171. |
|
|
Henry F, Moore JW (1996). Mathematical comparison of curves with an emphasis on dissolution profiles. Pharmaceutical Technology 20:64-74. |
|
|
Jerome PS, Gordon LA, William HB, Leslie ZB, James EC, Joseph RR, Vinod PS, Avrahma Y, Jean MA, Kenneth SA (1990). Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms. Journal of Pharmaceutical Science 79:849-854. |
|
|
Russell JR (1997). Examples of in vitro-in vivo relationships with a diverse range of quality. Biopharmaceutics. Purepac pharmaceutical co., a subsidiary of Faulding, Inc. New Jersey 07207. |
|
|
Sabahuddin S, Jasmina K, Papiya B (2010). Development of sustained release capsules containing "coated matrix granules of metoprolol tartrate". Aaps Pharmscitech 11(9):1306-1314. |
|
|
USP Subcommittee on Biopharmaceutics (1988). In-vitro-in vivo correlation for extended release oral dosage forms. Pharm. Forum, USA, July–Aug: 4160-4161. |
|
|
Ziad H, Michael F (1990). Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation. Pharmaceutical Research 7(11):1167-1171. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
